Description
Abiraterone Acetate, marketed under the brand name XBIRA, It is an prescription medication that has been approved abiraterone acetate for several uses, including:
Metastatic castration-resistant prostate cancer (CRPC): The FDA approved abiraterone acetate in 2011.
Metastatic high-risk castration-sensitive prostate cancer (CSPC): The FDA approved abiraterone acetate in combination with prednisone in 2018.
Fine-particle formulation: The FDA approved a fine-particle formulation of abiraterone acetate (Yonsa) in 2018. Yonsa is used in combination with methylprednisolone to treat patients with CRPC.
What is XBIRA (Abiraterone Acetate) ?
Abiraterone acetate, is an antiandrogen medication which is used in the treatment of prostate cancer. Xbira 250 mg Tablet is an anticancer drug used in men along with another drug called prednisone for the treatment of prostate cancer that has spread to other parts of the body. It is generally used in patients who are not responding to other treatment options.
The other clinical benefit with abiraterone acetate includes convenient once daily oral administration. XBIRA (abiraterone acetate) tablets are indicated in combination with prednisone for the treatment of patients with metastatic CRPC who have received prior chemotherapy containing docetaxel.
How to order approved “XBIRA (Abiraterone Acetate) for Tablets” Medicine?
XBIRA (Abiraterone Acetate) Tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing XBIRA and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.